Caterina Alfano, PhD
Group coordinator
calfano@fondazionerimed.com
Contact:
Viale delle Scienze, Ed. 18
90128 Palermo, ITALY
Facilities
Collaborations:
- King’s College London, London, United Kingdom
- EBRI – European Brain Research Institute Rita Levi-Montalcini, Rome, Italy
- Università degli studi della Campania “Luigi Vanvitelli”, Naples, Italy
- Università degli Studi di Palermo, Italy
- Institute of Biophysics (IBF-CNR), Palermo, Italy
- International Covid-19 NMR Consortium
- Institute of Nanotechnology (CNR NANOTEC), Lecce, Italy
- i3S Institute for Research and Innovation in Health, Porto, Portugal
Description
The Structural Biology and Biophysics group provides biophysical and structural information of biological phenomena guided by folding, aggregation, and interaction of proteins, with the ultimate goal of understanding the molecular mechanisms underlying serious pathologies. The group is also committed in small molecules-based drug discovery, and development of protein-based therapeutics with particular emphasis on therapeutic antibodies.
The main focus of the research activities of the group is on neurodegenerative diseases. Neurodegeneration is an increasing threat of our increasingly aging modern society. Current treatments are in the best-case palliative and non-specific, reflecting the fact that the detailed understanding of most of these diseases is still lacking. Our research aims to understand the molecular mechanisms of protein misfolding and aggregation behind neurodegenerative diseases as a key tool to design molecules that can specifically compete with pathological aggregation. Native protein-protein interactions could indeed provide important means of altering and controlling the function and assembly of proteins involved in neurodegenerative diseases, and could play a protective role against aberrant aggregation.
In parallel, the group is committed to the structural and biophysical characterization of Mussel Foot adhesive proteins, which, similarly to proteins involved in neurodegenerative diseases, undergo to phase transition and form stable protein aggregates. The final aim of this research project is the development of bio-adhesives able to work in wet environment. In the last years, there is a growing interest on the development of novel naturally-derived glues in several areas of clinical applications, such as tissue engineering, implantation of medical devices and wound closure. The big challenge in developing new bio-adhesive molecules is to find molecules able to work in wet and hostile environment and capable of making tissues adhere together in an efficient way in those conditions. Proteins from sessile animals with adhesive properties in water could overcome these difficulties.
Team